These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3124275)

  • 21. Recurrent deep vein thrombosis and Addison's disease in "primary" antiphospholipid syndrome.
    Asherson RA; Hughes GR
    J Rheumatol; 1989 Mar; 16(3):378-80. PubMed ID: 2498514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Procainamide-induced lupus in a patient with bilateral pleural effusion].
    Ohtani Y; Sumi Y; Hisauchi K; Sawada M; Miyake S; Yamashita Y; Mitunaga K; Yoshizawa Y
    Nihon Kokyuki Gakkai Zasshi; 1998 Jun; 36(6):535-40. PubMed ID: 9754005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The course of pregnancy in lupus anticoagulant syndrome].
    Spitzer D; Staudach A; Riedl B; Traun H; Steiner H
    Geburtshilfe Frauenheilkd; 1990 Aug; 50(8):644-6. PubMed ID: 2120107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acetylprocainamide therapy in patients with previous procainamide-induced lupus syndrome.
    Kluger J; Drayer DE; Reidenberg MM; Lahita R
    Ann Intern Med; 1981 Jul; 95(1):18-23. PubMed ID: 6166229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lupus anticoagulant inhibition of in vitro prostacyclin release is associated with a thrombosis-prone subset of patients.
    Watson KV; Schorer AE
    Am J Med; 1991 Jan; 90(1):47-53. PubMed ID: 1898838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acetylation status is associated with serological changes but not clinically significant disease in patients receiving procainamide.
    Mongey AB; Sim E; Risch A; Hess E
    J Rheumatol; 1999 Aug; 26(8):1721-6. PubMed ID: 10451068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiphospholipid antibodies: predictive value of laboratory tests.
    Galli M; Finazzi G; Barbui T
    Thromb Haemost; 1997 Jul; 78(1):75-8. PubMed ID: 9198131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lupus anticoagulant.
    Williams PE
    J Ark Med Soc; 1990 May; 86(12):493-7. PubMed ID: 2140351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lupus anticoagulant. Coagulation inhibitor associated with thrombosis tendency].
    Wisløff F; Godal HC; Gaarder PI; Langebrekke A
    Tidsskr Nor Laegeforen; 1987 May; 107(13):1128-30. PubMed ID: 3111007
    [No Abstract]   [Full Text] [Related]  

  • 30. The lupus anticoagulant.
    Lands RH
    J Tenn Med Assoc; 1987 Mar; 80(3):135-7. PubMed ID: 3104686
    [No Abstract]   [Full Text] [Related]  

  • 31. [Obstetric and thrombotic complications in women with lupus anticoagulant].
    Ordi Ros J; Vilardell Tarrés M; Barquinero Máñez J; Bosch Gil J; Rodrigo MJ; Monasterio Aspiri Y
    Med Clin (Barc); 1988 Jan; 90(1):11-3. PubMed ID: 3126370
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome.
    Woosley RL; Drayer DE; Reidenberg MM; Nies AS; Carr K; Oates JA
    N Engl J Med; 1978 May; 298(21):1157-9. PubMed ID: 306574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous procainamide-induced immune thrombocytopenia and lupus anticoagulant.
    Freeman NJ; Fajardo L; Carvalho A
    Am J Hematol; 1995 Feb; 48(2):133-4. PubMed ID: 7847333
    [No Abstract]   [Full Text] [Related]  

  • 34. Immune regulatory abnormalities produced by procainamide.
    Miller KB; Salem D
    Am J Med; 1982 Oct; 73(4):487-92. PubMed ID: 6214945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IgG but not other classes of anti-[(H2A-H2B)-DNA] is an early sign of procainamide-induced lupus.
    Rubin RL; Burlingame RW; Arnott JE; Totoritis MC; McNally EM; Johnson AD
    J Immunol; 1995 Mar; 154(5):2483-93. PubMed ID: 7868914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Procainamide-induced lupus erythematosus pericarditis encountered during coronary bypass sugery.
    Goldberg MJ; Husain M; Wajszczuk WJ; Rubenfire M
    Am J Med; 1980 Jul; 69(1):159-62. PubMed ID: 6155782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Renal cortex ischemia, right atrial thrombosis and coronary occlusion in anti-phospholipid antibody syndrome].
    Ramdane M; Gryman R; Bacques O; Callard P; Kleinknecht D
    Nephrologie; 1989; 10(4):189-93. PubMed ID: 2517317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphocyte alteration by procainamide: relation to drug-induced lupus erythematosus syndrome.
    Bluestein HG; Zvaifler NJ; Weisman MH; Shapiro RF
    Lancet; 1979 Oct; 2(8147):816-9. PubMed ID: 90917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired fibrinolysis as an essential contribution to thrombosis in patients with lupus anticoagulant.
    Tsakiris DA; Marbet GA; Makris PE; Settas L; Duckert F
    Thromb Haemost; 1989 Apr; 61(2):175-7. PubMed ID: 2501894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiphospholipid antibodies.
    Levine SR; Welch KM
    Ann Neurol; 1989 Sep; 26(3):386-9. PubMed ID: 2508536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.